Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer Marc Margolis, MD, Pendleton Alexander, MD, Gregory D Trachiotis, MD, Farid Gharagozloo, MD, Timothy Lipman, MD The Annals of Thoracic Surgery Volume 76, Issue 5, Pages 1694-1698 (November 2003) DOI: 10.1016/S0003-4975(02)04890-7
Fig 1 Actuarial survival for patients in whom percutaneous endoscopic gastrostomy (PEG) was possible (straight line) and for patients in whom it was not possible (dashed line). The difference in survival showed a trend toward significance (log rank p = 0.086). The Annals of Thoracic Surgery 2003 76, 1694-1698DOI: (10.1016/S0003-4975(02)04890-7)